Species distribution and resistance profile of clinical isolates from an intensive care unit during pre- and post-COVID-19 pandemic periods

1 Parisini A, Boni S, Vacca EB, Bobbio N, Del Puente F, Feasi M, et al. Impact of the COVID-19 Pandemic on Epidemiology of Antibiotic Resistance in an Intensive Care Unit (ICU): The Experience of a North-West Italian Center. Antibiotics (Basel). 2023;12(8):1278. DOI: 10.3390/antibiotics12081278 Search in Google Scholar

2 Boccabella L, Palma EG, Abenavoli L, Scarlata GGM, Boni M, Ianiro G, et al. Post-Coronavirus Disease 2019 Pandemic Antimicrobial Resistance. Antibiotics (Basel). 2024;13(3):233. DOI: 10.3390/antibiotics13030233 Search in Google Scholar

3 Malik SS, Mundra S. Increasing Consumption of Antibiotics during the COVID-19 Pandemic: Implications for Patient Health and Emerging Anti-Microbial Resistance. Antibiotics (Basel). 2022;12(1):45. DOI: 10.3390/antibiotics12010045 Search in Google Scholar

4 Magiorakos AP, Srinivasan A, Carey RB, Carmeli Y, Falagas ME, Giske CG, et al. Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. Clin Microbiol Infect. 2012;18:268-81. DOI: 10.1111/j.1469-0691.2011.03570.x Search in Google Scholar

5 Su C, Zhang Z, Zhao X, Peng H, Hong Y, Huang L, et al. Changes in prevalence of nosocomial infection pre- and post-COVID-19 pandemic from a tertiary Hospital in China. BMC Infect Dis. 2021;21:693. DOI: 10.1186/s12879-021-06396-x Search in Google Scholar

6 Huang H, Wu K, Chen H, Wang J, Chen L, Lai Z, Lin S. The impact of the COVID-19 pandemic on nosocomial infections: a retrospective analysis in a tertiary maternal and child healthcare hospital. Front Public Health. 2023; 11:1132323. DOI: 10.3389/fpubh.2023.1132323 Search in Google Scholar

7 Witt LS, Howard-Anderson JR, Jacob JT, Gottlieb LB. The impact of COVID-19 on multidrug-resistant organisms causing healthcare-associated infections: a narrative review. JAC-Antimicrobial Resistance. 2023; 5(1):dlac130. DOI: 10.1093/jacamr/dlac130 Search in Google Scholar

8 Lepape A, Machut A, Bretonnière C, Friggeri A, Vacheron CH, Savey A. Effect of SARS-CoV-2 infection and pandemic period on healthcare-associated infections acquired in intensive care units. Clin Microbiol Infect. 2023; 29(4):530-6. DOI: 10.1016/j.cmi.2022.10.023 Search in Google Scholar

9 Nori P, Cowman K, Chen V, Bartash R, Szymczak W, Madaline T, et al. Bacterial and fungal coinfections in COVID-19 patients hospitalized during the New York city pandemic surge. Infect Control Hosp Epidemiol. 2021; 42:84-8. DOI: 10.1017/ice.2020.368 Search in Google Scholar

10 Golli AL, Zlatian OM, Cara ML, Olteanu M. Pre- and Post-COVID-19 Antimicrobial Resistance Pattern of Pathogens in an Intensive Care Unit. Pharmaceuticals. 2024 Mar 22;17(4):407. DOI: 10.3390/ph17040407 Search in Google Scholar

11 Langford BJ, So M, Raybardhan S, Leung V, Westwood D, MacFadden DR, et al. Bacterial co-infection and secondary infection in patients with COVID-19: a living rapid review and meta-analysis. Clin Microbiol Infect. 2020; 26:1622-9. DOI: 10.1016/j.cmi.2020.07.016 Search in Google Scholar

12 Vulcanescu DD, Avram CR, Oprison LA, Tanasescu S, Sorescu T, Susan R, et al. Bacterial Infections, Trends, and Resistance Patterns in the Time of the COVID-19 Pandemic in Romania-A Systematic Review. Antibiotics. 2024 Dec 14;13(12):1219. DOI: 10.3390/antibiotics13121219 Search in Google Scholar

13 Mares C, Petca RC, Petca A, Popescu RI, Jinga V. Does the COVID Pandemic Modify the Antibiotic Resistance of Uropathogens in Female Patients? A New Storm? Antibiotics. 2022;11:376. DOI: 10.3390/antibiotics11030376 Search in Google Scholar

14 Mares C, Petca RC, Popescu RI, Petca A, Geavlete BF, Jinga V. Uropathogens’ Antibiotic Resistance Evolution in a FemalePopulation: A Sequential Multi-Year Comparative Analysis. Antibiotics. 2023;12:948. DOI: 10.3390/antibiotics12060948 Search in Google Scholar